US Patent Issued to UNIVERSITY OF IOWA RESEARCH FOUNDATION on June 24 for "Structural optimization method to improve the theranostic performance of peptide receptor-targeted radionuclide therapy for cancers" (Iowa Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,337,042, issued on June 24, was assigned to UNIVERSITY OF IOWA RESEARCH FOUNDATION (Iowa City, Iowa).

"Structural optimization method to improve the theranostic performance of peptide receptor-targeted radionuclide therapy for cancers" was invented by Dongyoul Lee (Iowa City, Iowa), Michael K. Schultz (Iowa City, Iowa), Mengshi Li (Iowa City, Iowa), Nicholas Baumhover (Iowa City, Iowa) and F. Christopher Pigge (Iowa City, Iowa).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides in certain embodiments a carcinoma-targeting conjugate comprising Formula I:T-L-X wherein T is a SSTR2 targeting ligand, L is a linker, and X is a chela...